A new study reports the locus coeruleus, an area of the brain essential for maintaining cognitive function, is vulnerable to toxins and infections. This brain area appears to be the first place affected by late onset Alzheimer's.
Researchers have revealed a new, non-invasive, pre-clinical biomarker for Alzheimer's disease.
Using neurons created from iPS cells derived from people with ALS, researchers develop a new drug which appears to halt the impact of the genetic mutations in some forms of ALS and dementia.
Researchers report dysfunctional mitophagy may contribute to the development of Alzheimer's disease. When mitophagy is improved, symptoms of Alzheimer's almost disappeared in animal models of the disease.
MicroRNA-132 regulates neurogenesis in the hippocampus, according to both mouse and human tissue studies. Restoring levels of microRNA-132 in mouse models of Alzheimer's disease reduces neurogenetic deficits and restores cognitive abilities, researchers say.
Researchers discover so-called sticky synapses can impair new learning by excessively hard wiring old memories.
According to researchers, a simple MRI brain scan could help diagnose people with a common cognitive disorder.
A study that used postmortem brain tissue samples from Alzheimer's patients and mouse models found the hunger hormone ghrelin is linked to cognitive impairments and memory loss associated with the disease.
Researchers use peanut butter as a new tool to diagnose early stage Alzheimer's disease.